HCPCS Level II drug code
Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
In short
Q9967 is the HCPCS Level II code for low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml. CMS assigns NDCs for Iodixanol, Iomeron, Iopamidol and Ioversol Injection 678 MG/ML and 13 more to it. The Medicare Part B payment limit is $0.186 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Short descriptor
- Locm 300-399mg/ml iodine,1ml
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2008
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under Q9967
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 95 NDCs to Q9967 for Iodixanol, Iomeron, Iopamidol, Ioversol Injection 678 MG/ML, Ioversol Injection 741 MG/ML, Isovue-300, Isovue-370, Isovue-M-300, Omnipaque 300, Omnipaque 300 (Novaplus), Omnipaque 350, Omnipaque 350 (Novaplus), Optiray 320, Optiray 350, Ultravist 300, Ultravist 370 and Visipaque 320. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Iodixanol | 65219-0383-05 | FreseniUS Kabi USA, LLC | 10 × 50 | 500 |
| Iodixanol | 65219-0383-10 | FreseniUS Kabi USA, LLC | 10 × 100 | 1,000 |
| Iodixanol | 65219-0383-50 | FreseniUS Kabi USA, LLC | 10 × 150 | 1,500 |
| Iodixanol | 65219-0383-70 | FreseniUS Kabi USA, LLC | 10 × 200 | 2,000 |
| Iodixanol | 70436-0126-82 | Slate Run Pharmaceuticals | 10 × 15 | 150 |
| Iomeron | 00270-7300-10 | Bracco Diagnostics Inc. | 56 × 100 | 5,600 |
| Iomeron | 00270-7300-20 | Bracco Diagnostics Inc. | 10 × 200 | 2,000 |
| Iopamidol | 70436-0127-82 | Slate Run Pharmaceuticals | 10 × 100 | 1,000 |
| Iopamidol | 70436-0219-52 | Slate Run Pharmaceuticals | 10 × 30 | 300 |
| Iopamidol | 70436-0219-62 | Slate Run Pharmaceuticals | 10 × 50 | 500 |
| Iopamidol | 70436-0219-82 | Slate Run Pharmaceuticals | 10 × 100 | 1,000 |
| Ioversol Injection 678 MG/ML | 00019-1323-65 | Liebel-Flarsheim Company LLC | 6 × 500 | 3,000 |
| Ioversol Injection 741 MG/ML | 00019-1333-65 | Liebel-Flarsheim Company LLC | 6 × 500 | 3,000 |
| Isovue-300 | 00270-1315-25 | Bracco Diagnostics Inc. | 10 × 30 | 300 |
| Isovue-300 | 00270-1315-35 | Bracco Diagnostics Inc. | 10 × 100 | 1,000 |
| Isovue-300 | 00270-1315-45 | Bracco Diagnostics Inc. | 10 × 200 | 2,000 |
| Isovue-300 | 00270-1315-95 | Bracco Diagnostics Inc. | 6 × 500 | 3,000 |
| Isovue-370 | 00270-1316-35 | Bracco Diagnostics Inc. | 10 × 100 | 1,000 |
| Isovue-370 | 00270-1316-45 | Bracco Diagnostics Inc. | 10 × 200 | 2,000 |
| Isovue-370 | 00270-1316-95 | Bracco Diagnostics Inc. | 6 × 500 | 3,000 |
| Isovue-M-300 | 00270-1412-15 | Bracco Diagnostics Inc. | 10 × 15 | 150 |
| Omnipaque 300 | 00407-1413-10 | GE Healthcare Inc. | 10 × 10 | 100 |
| Omnipaque 300 | 00407-1413-53 | GE Healthcare Inc. | 10 × 125 | 1,250 |
| Omnipaque 300 | 00407-1413-59 | GE Healthcare Inc. | 10 × 30 | 300 |
| Omnipaque 300 | 00407-1413-61 | GE Healthcare Inc. | 10 × 50 | 500 |
| Omnipaque 300 | 00407-1413-62 | GE Healthcare Inc. | 10 × 75 | 750 |
| Omnipaque 300 | 00407-1413-63 | GE Healthcare Inc. | 10 × 100 | 1,000 |
| Omnipaque 300 | 00407-1413-65 | GE Healthcare Inc. | 10 × 150 | 1,500 |
| Omnipaque 300 | 00407-1413-66 | GE Healthcare Inc. | 10 × 200 | 2,000 |
| Omnipaque 300 | 00407-1413-68 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 300 | 00407-1413-69 | GE Healthcare Inc. | 10 × 125 | 1,250 |
| Omnipaque 300 | 00407-1413-72 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 300 | 00407-1413-86 | GE Healthcare Inc. | 10 × 50 | 500 |
| Omnipaque 300 | 00407-1413-87 | GE Healthcare Inc. | 10 × 100 | 1,000 |
| Omnipaque 300 | 00407-1413-88 | GE Healthcare Inc. | 10 × 150 | 1,500 |
| Omnipaque 300 | 00407-1413-89 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 300 (Novaplus) | 00407-1413-48 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 350 | 00407-1414-72 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 350 | 00407-1414-76 | GE Healthcare Inc. | 10 × 125 | 1,250 |
| Omnipaque 350 | 00407-1414-82 | GE Healthcare Inc. | 10 × 50 | 500 |
| Omnipaque 350 | 00407-1414-84 | GE Healthcare Inc. | 10 × 100 | 1,000 |
| Omnipaque 350 | 00407-1414-85 | GE Healthcare Inc. | 10 × 125 | 1,250 |
| Omnipaque 350 | 00407-1414-86 | GE Healthcare Inc. | 10 × 150 | 1,500 |
| Omnipaque 350 | 00407-1414-87 | GE Healthcare Inc. | 10 × 200 | 2,000 |
| Omnipaque 350 | 00407-1414-88 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 350 | 00407-1414-89 | GE Healthcare Inc. | 10 × 50 | 500 |
| Omnipaque 350 | 00407-1414-90 | GE Healthcare Inc. | 10 × 75 | 750 |
| Omnipaque 350 | 00407-1414-91 | GE Healthcare Inc. | 10 × 100 | 1,000 |
| Omnipaque 350 | 00407-1414-93 | GE Healthcare Inc. | 10 × 150 | 1,500 |
| Omnipaque 350 | 00407-1414-94 | GE Healthcare Inc. | 10 × 200 | 2,000 |
| Omnipaque 350 | 00407-1414-95 | GE Healthcare Inc. | 10 × 125 | 1,250 |
| Omnipaque 350 | 00407-1414-98 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Omnipaque 350 (Novaplus) | 00407-1414-48 | GE Healthcare Inc. | 10 × 500 | 5,000 |
| Optiray 320 | 00019-1323-06 | Liebel-Flarsheim Company LLC | 25 × 50 | 1,250 |
| Optiray 320 | 00019-1323-11 | Liebel-Flarsheim Company LLC | 12 × 100 | 1,200 |
| Optiray 320 | 00019-1323-16 | Liebel-Flarsheim Company LLC | 12 × 150 | 1,800 |
| Optiray 320 | 00019-1323-21 | Liebel-Flarsheim Company LLC | 12 × 200 | 2,400 |
| Optiray 320 | 00019-1323-52 | Liebel-Flarsheim Company LLC | 20 × 50 | 1,000 |
| Optiray 320 | 00019-1323-78 | Liebel-Flarsheim Company LLC | 20 × 50 | 1,000 |
| Optiray 320 | 00019-1323-87 | Liebel-Flarsheim Company LLC | 20 × 125 | 2,500 |
Showing 60 of 95. The full list is in the CMS crosswalk file.
Q9967: common questions
- Is Q9967 a CPT code?
- No. Q9967 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under Q9967?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 95 NDCs under Q9967, for Iodixanol, Iomeron, Iopamidol, Ioversol Injection 678 MG/ML, Ioversol Injection 741 MG/ML and Isovue-300 and 11 more. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for Q9967?
- $0.186 per 1 ml, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.